Literature DB >> 15724432

Bovine hexokinase type I: full-length cDNA sequence and characterisation of the recombinant enzyme.

Francesca Andreoni1, Giordano Serafini, Maria Elena Laguardia, Mauro Magnani.   

Abstract

This study reports the revised and full-length cDNA sequence of bovine hexokinase type I obtained from bovine brain. Since dissimilarities have been observed between the published bovine hexokinase type I coding sequence (GenBank accession no. M65140) (Genomics 11: 1014-1024, 1991) and an analysed portion of bovine hexokinase type I gene, the entire open reading frame was re-sequenced and the ends of cDNA isolated by rapid amplification of cDNA ends. The coding sequences, when compared with the published bovine hexokinase type I, contained a large number of mismatches that lead to changes in the resulting amino acid sequence. The revisions result in a hexokinase type I cDNA of 3619 bp that encodes a protein of 917 amino acids highly homologous to human hexokinase type I. The expression of the recombinant full-length enzyme demonstrated that it was a catalytically active hexokinase. When characterised for its kinetic and regulatory properties, it displayed the same affinity for glucose and MgATP as the human hexokinase type I and was inhibited by glucose 6-phosphate competitively versus MgATP. The production of the N- and C-terminal recombinant halves of the enzyme followed by comparison with the full-length hexokinase indicated that the catalytic activity is located in the C-terminal domain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15724432     DOI: 10.1007/s11010-005-1846-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Functional interactions between the noncovalently associated N- and C-terminal halves of mammalian Type I hexokinase.

Authors:  Dexin Sui; John E Wilson
Journal:  Arch Biochem Biophys       Date:  2002-05-01       Impact factor: 4.013

2.  Amplification of cDNA ends based on template-switching effect and step-out PCR.

Authors:  M Matz; D Shagin; E Bogdanova; O Britanova; S Lukyanov; L Diatchenko; A Chenchik
Journal:  Nucleic Acids Res       Date:  1999-03-15       Impact factor: 16.971

3.  'Touchdown' PCR to circumvent spurious priming during gene amplification.

Authors:  R H Don; P T Cox; B J Wainwright; K Baker; J S Mattick
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

4.  Residues putatively involved in binding of ATP and glucose 6-phosphate to a mammalian hexokinase: site-directed mutation at analogous positions in the N- and C-terminal halves of the type I isozyme.

Authors:  M Baijal; J E Wilson
Journal:  Arch Biochem Biophys       Date:  1995-08-20       Impact factor: 4.013

5.  Structure of the gene for type I hexokinase from rat.

Authors:  J A White; J E Wilson
Journal:  Arch Biochem Biophys       Date:  1997-07-15       Impact factor: 4.013

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Functional organization of mammalian hexokinases: both N- and C-terminal halves of the rat type II isozyme possess catalytic sites.

Authors:  H J Tsai; J E Wilson
Journal:  Arch Biochem Biophys       Date:  1996-05-01       Impact factor: 4.013

8.  Multiple crystal forms of hexokinase I: new insights regarding conformational dynamics, subunit interactions, and membrane association.

Authors:  A E Aleshin; H J Fromm; R B Honzatko
Journal:  FEBS Lett       Date:  1998-08-28       Impact factor: 4.124

9.  Enzymatic properties of overexpressed human hexokinase fragments.

Authors:  M Bianchi; G Serafini; E Bartolucci; C Giammarini; M Magnani
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

10.  Functional organization of mammalian hexokinases: characterization of chimeric hexokinases constructed from the N- and C-terminal domains of the rat type I and type II isozymes.

Authors:  H J Tsai; J E Wilson
Journal:  Arch Biochem Biophys       Date:  1995-01-10       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.